| Line 22: |
Line 22: |
| | ===Clinical Signs=== | | ===Clinical Signs=== |
| | *Vomiting | | *Vomiting |
| − | *Diarrhoea; small or large intestinal depnding on part of the gastrointestinal tract affected | + | *Diarrhoea; small intestinal is more common |
| | **Haematoemesis or malena, and/or haematochezia; EGE is associated with mucosal erosion or ulceration | | **Haematoemesis or malena, and/or haematochezia; EGE is associated with mucosal erosion or ulceration |
| | *Protein-losing enteropathy in severe cases | | *Protein-losing enteropathy in severe cases |
| Line 31: |
Line 31: |
| | ===Laboratory Tests=== | | ===Laboratory Tests=== |
| | ====Haematology==== | | ====Haematology==== |
| − | | + | *Anaemia if gastrointestinal haemorrhage is severe. |
| | | | |
| | ====Biochemistry==== | | ====Biochemistry==== |
| Line 37: |
Line 37: |
| | **This is not always present. Even when present, alone, it cannot prove the presence of EE. | | **This is not always present. Even when present, alone, it cannot prove the presence of EE. |
| | **It is also a marker for parasitism, hypoadrenocorticism, allergic dermatological disease, allergic respiratory disease and mast cell tumour. | | **It is also a marker for parasitism, hypoadrenocorticism, allergic dermatological disease, allergic respiratory disease and mast cell tumour. |
| | + | *Panhypoproteinaemia |
| | + | **Secoondary to concurrent protein-losing enteropathy |
| | + | |
| | | | |
| | ====Other Tests==== | | ====Other Tests==== |
| Line 42: |
Line 45: |
| | | | |
| | ===Diagnostic Imaging=== | | ===Diagnostic Imaging=== |
| − | | + | *Endoscopically, linear ulcers within the duodenal mucosa may be seen grossly. |
| | | | |
| | | | |
| Line 49: |
Line 52: |
| | | | |
| | ==Treatment== | | ==Treatment== |
| | + | *Anti-parasiticide |
| | + | **Fenbendazole may be given due to the possible endoparasitism or dietary sensitivity |
| | *Dietary modification | | *Dietary modification |
| | **A hypoallergenic diet should be used | | **A hypoallergenic diet should be used |
| Line 54: |
Line 59: |
| | | | |
| | Refer to [[Inflammatory Bowel Disease - WikiClinical #Treatment|IBD]] for further information | | Refer to [[Inflammatory Bowel Disease - WikiClinical #Treatment|IBD]] for further information |
| − |
| |
| | | | |
| | | | |
| | ==Prognosis== | | ==Prognosis== |
| − | | + | Guarded if the initial response to treatment is poor. Good if the underlying cause is detected and successfully treated. |
| | | | |
| | | | |